Intellia Therapeutics Inc (NASDAQ:NTLA)

31.99
Delayed Data
As of 4:00pm ET
 +0.01 / +0.03%
Today’s Change
16.33
Today|||52-Week Range
35.99
+66.44%
Year-to-Date

Today’s Trading

Previous close31.98
Today’s open31.51
Day’s range31.51 - 32.70
Volume539,478
Average volume (3 months)768,980
Market cap$1.4B
Data as of 4:00pm ET, 09/19/2018

Growth & Valuation

Earnings growth (last year)-32.39%
Earnings growth (this year)-7.02%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.49%
P/E ratioNM
Price/Sales26.50
Price/Book4.51

Competitors

 Today’s
change
Today’s
% change
DCPHDeciphera Pharmaceut...+0.28+0.78%
IMGNImmunoGen Inc-0.22-2.43%
QUREUniqure NV-1.34-3.36%
BOLDAudentes Therapeutic...-0.67-1.67%
Data as of 4:00pm ET, 09/19/2018

Financials

Next reporting dateOctober 30, 2018
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$26.1M
Annual profit (last year)-$67.5M
Net profit margin-258.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John M. Leonard
Executive Vice President &
General Counsel
Jose E. Rivera
Corporate headquarters
Cambridge, Massachusetts

Forecasts